LOS ANGELES--(BUSINESS WIRE)--Lundin Law PC announces it is investigating claims against Globus Medical, Inc. (“Globus” or the “Company”) (NYSE:GMED) concerning possible violations of federal securities laws between February 26, 2014 and August 5, 2014. The investigation is related to allegations that certain statements issued by Globus were false and misleading concerning the Company’s financial performance.
To join this class action lawsuit, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or via e-mail at email@example.com.
The investigation will focus on whether the Company made misleading statements and/or failed to disclose that: (a) Globus Medical’s relationship with a significant distributor was deteriorating; (b) such deterioration was negatively impacting Globus Medical’s financial performance; and (c) as a result of the foregoing, defendants’ statements about the Company’s business and operations were false and misleading. When the truth was revealed to the investing public, shares dropped causing investors harm.
No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.